Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Helix BioMedix has entered into a manufacturing and supply agreement with Solvay's affiliate Peptisyntha, which will manufacture and supply to Helix BioMedix its requirements for certain peptides at specified prices for an initial term of two years.
Subscribe to our email newsletter
Stephen Beatty, president and CEO of Helix BioMedix, said: “This agreement is significant for Helix BioMedix as it addresses several critical components that are important to the company both now and in the future.
“First, our relationship with Peptisyntha is a major step towards ensuring that we can supply commercial quantities of peptides once products are developed through our pharmaceutical program. Second, this agreement will immediately provide peptide supplies to our marketing partners for our rapidly growing consumer product segment.”